Novel microminipig model of atherosclerosis by high fat and high cholesterol diet, established in Japan

In Vivo

Volumn 24, Issue 5, 2010, Pages 671-680

  Miyoshi, Noriakj ^a   Horiuchi, Masahisa ^a   Inokuchi, Yoshinori ^a   Miyamoto, Yoko ^a   Miura, Naoki ^a   Tokunaga, Satatoshi ^a   Fujiki, Makoto ^a   Izumi, Yasukatsu ^c   Miyajima, Hiroaki ^d   Nagata, Ryoichi ^d   Misumi, Kazuhiro ^a   Takeuchi, Toru ^a   Tanimoto, Akihide ^a   Yasuda, Nobuhiro ^a   Yoshida, Hiroki ^b   Kawaguchi, Hiroaki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

Atherosclerosis; Cholesterol; Diet; Life style; Minipig

Indexed keywords

CHOLESTEROL; CHOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; FEMALE; HYPERCHOLESTEROLEMIA; JAPAN; LIPID DIET; MALE; MICROMINIPIG; MINIPIG; NONHUMAN; OVARIECTOMY;

EID: 78649287538     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. th edn. Kumar V, Abbas AK and Faust N (eds.). Philadelphia, USA: Saunders, pp. 511-554, 2005.
2. Washio M, Sasazuki S, Kodama H, Yoshimasu PK, Liu Y, Tanaka K, Tokunaga S, Kono PS, Arai H, Koyanagi S, Hiyamuta K, Doi Y, Kawano MT, Nakagaki MO, Takada K, Nii MT, Shirai K, Ideishi MM, Arakawa MK, Mohri MM and Takeshita A: Role of hypertension, dyslipidemia and diabetes mellitus in the development of coronary atherosclerosis in Japan. Jpn Circ J 65: 731-737, 2001.
3. Turk JR, Henderson KK, Vanvickle GD, Watkins J and Laughlin MH: Arterial endothelial function in a porcine model of early-stage artherosclerotic disease. Int J Exp Path 86: 335-345, 2005.
4. Xi S, Yin W, Wang Z, Kusunoki M, Lian X, Koike T, Fan J and Zhang Q: A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int J Exp Path 85: 223-231, 2004.
5. Reddick RL, Zhang SH and Maeda N: Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14: 141-147, 1994.
6. van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH and Havekes LM: Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 93: 1403-1410, 1994.
7. Buja LM, Kita T, Goldstein JL, Watanabe Y and Brown MS: Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 3: 87-101, 1983.
8. Shiomi M, Ito T, Tsukada T, Yata T and Ueda M: Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. An immunohistochemical study. Arterioscler Thromb 14: 931-937, 1994.
9. Goodrich JA, Clarkson TB, Cline JM, Jenkins AJ and Del Signore MJ: Value of the micropig model of menopause in the assessment of benefits and risks of postmenopausal therapies for cardiovascular and reproductive tissues. Fertil Steril 79(Suppl 1): 779-788, 2003.
10. nd edn. Bollen PJA, Hansen AK, Rasmussen HJ and Suckow MA (eds.). New York, USA: CRC Press, pp. 1-14, 2010.
11. Svendsen O: The minipig in toxicology. Exp Toxicol Pathol 57: 335-339, 2006.
12. Swindle MM: Cardiovascular catheterization, electrophysiology, and imaging laboratory procedures. In: Swine in the Laboratory. Swindle MM (ed.). New York, USA: CRC Press, pp. 299-343, 2007.
13. Kamimura R, Miura N and Suzuki S: The hemodynamic effects of acute myocardial ischemia and reperfusion in Clawn miniature pigs. Exp Anim 52: 335-338, 2003.
14. Murayama N, Kaneko N, Horiuchi K, Ohyama K, Shimizu M, Ito K and Yamazaki H: Cytochrome P450-dependent drug oxidation activity of liver microsomes from Microminipigs, a possible new animal model for humans in non-clinical studies. Drug Metab Pharmacokinet 24: 404-408, 2009.
15. Stary HC: Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20: 1177-1178, 2000.
16. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD and Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374, 1995.
17. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD and Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89: 2462-2478, 1994.
18. Hifumi T, Miyoshi N, Kawaguchi H, Nomura K and Yasuda N: Immunohistochemical detection of proteins associated with multidrug resistance to anticancer drugs in canine and feline primary pulmonary carcinoma. J Vet Med Sci 72: 665-668, 2010.
19. Tokgözoǧlu L and Bariş Kaya E: Atherosclerotic vascular disease and risk factors in Turkey: from past to present. J Atheroscler Thromb 15: 286-291, 2008.
20. Ostlund-Lindqvist AM, Lindqvist P, Bräutigam J, Olsson G, Bondjers G and Nordborg C: Effect of metoprolol on diet-induced atherosclerosis in rabbits. Arteriosclerosis 8: 40-45, 1988.
21. Kim CJ, Jang HC, Cho DH and Min YK: Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscler Thromb 14: 275-281, 1994.
22. Wassmann K, Wassmann S and Nickenig G: Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 97: 1046-1054, 2005.
23. Zhu X, Bonet B, Gillenwater H and Knopp RH: Opposing effects of estrogen and progestins on LDL oxidation and vascular wall cytotoxicity: implications for atherogenesis. Proc Soc Exp Biol Med 222: 214-221, 1999.
24. Lamon-Fava S, Ordovas JM and Schaefer EJ: Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 19: 2960-2965, 1999.
25. Itabe H: Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 26: 1-9. 2003.
26. Yamada S, Wang KY, Tanimoto A, Fan J, Shimajiri S, Kitajima S, Morimoto M, Tsutsui M, Watanabe T, Yasumoto K and Sasaguri Y: Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. Am J Pathol 172: 1419-1429, 2008.